Neil JohnsonPurchase02/11/2026350,000 shares£64,162.00Charlie Cannon BrookesPurchase02/11/2026181,033 shares£3,331,007.20Arlington Asset Management LimitedPurchase02/11/2026181,819 shares£3,345,469.60Charlie Cannon BrookesPurchase23/01/2026811,779 shares£219,748.58Neil JohnsonSale31/03/2022370,600 shares£107,511.06DateDirector/PDMRTypeSharesPriceValue02/11/2026Neil JohnsonPurchase350,0001,833.00£64,162.0002/11/2026Charlie Cannon BrookesPurchase181,0331,840.00£3,331,007.2002/11/2026Arlington Asset Management LimitedPurchase181,8191,840.00£3,345,469.6023/01/2026Charlie Cannon BrookesPurchase811,77927.07£219,748.5831/03/2022Neil JohnsonSale370,60029.01£107,511.06
Neil JohnsonPurchase02/11/2026350,000 shares£64,162.00Charlie Cannon BrookesPurchase02/11/2026181,033 shares£3,331,007.20Arlington Asset Management LimitedPurchase02/11/2026181,819 shares£3,345,469.60Charlie Cannon BrookesPurchase23/01/2026811,779 shares£219,748.58Neil JohnsonSale31/03/2022370,600 shares£107,511.06DateDirector/PDMRTypeSharesPriceValue02/11/2026Neil JohnsonPurchase350,0001,833.00£64,162.0002/11/2026Charlie Cannon BrookesPurchase181,0331,840.00£3,331,007.2002/11/2026Arlington Asset Management LimitedPurchase181,8191,840.00£3,345,469.6023/01/2026Charlie Cannon BrookesPurchase811,77927.07£219,748.5831/03/2022Neil JohnsonSale370,60029.01£107,511.06